| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.003 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.005 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |